Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 6 days ago“With five vaccine programmes that have achieved positive Phase III results, Moderna's platform is...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 3 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
The Joplin Globe· 7 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-< ...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 7 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 7 days agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days ago“Everybody talks about these changing symptoms,” says Dr. David Smith, head of the University of...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 12 hours agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
...Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 ...
NewMediaWire via Yahoo Finance· 2 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...